Trials / Sponsors / Suzhou Junjing BioSciences Co., Ltd.

Suzhou Junjing BioSciences Co., Ltd.

Industry · 7 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Active Not Recruiting	A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Pat Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly	Phase 1 / Phase 2	2025-07-28
Recruiting	JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations NSCLC	Phase 1 / Phase 2	2025-04-30
Terminated	A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer Locally Advanced or Metastatic NSCLC	Phase 1 / Phase 2	2022-10-11
Terminated	A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors Advanced Solid Tumors	Phase 1	2022-08-23
Terminated	A Study of WJ05129 in Advanced Malignant Solid Tumors Locally Advanced or Metastatic Malignant Solid Tumors	Phase 1 / Phase 2	2022-04-19
Terminated	The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer Advanced Hematologic Malignancies, Advanced Solid Tumors	Phase 1	2021-09-10
Unknown	AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer Lung Cancer	Phase 1 / Phase 2	2021-07-13